213 related articles for article (PubMed ID: 12106632)
1. Genomic and nongenomic effects of estrogen in the vasculature.
Mendelsohn ME
Am J Cardiol; 2002 Jul; 90(1A):3F-6F. PubMed ID: 12106632
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.
Chen Z; Yuhanna IS; Galcheva-Gargova Z; Karas RH; Mendelsohn ME; Shaul PW
J Clin Invest; 1999 Feb; 103(3):401-6. PubMed ID: 9927501
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of estrogen on the cardiovascular system.
Mendelsohn ME
Am J Cardiol; 2002 Jun; 89(12A):12E-17E; discussion 17E-18E. PubMed ID: 12084397
[TBL] [Abstract][Full Text] [Related]
4. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene.
Simoncini T; Genazzani AR; Liao JK
Circulation; 2002 Mar; 105(11):1368-73. PubMed ID: 11901050
[TBL] [Abstract][Full Text] [Related]
5. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae.
Kim HP; Lee JY; Jeong JK; Bae SW; Lee HK; Jo I
Biochem Biophys Res Commun; 1999 Sep; 263(1):257-62. PubMed ID: 10486286
[TBL] [Abstract][Full Text] [Related]
6. Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase.
Figtree GA; McDonald D; Watkins H; Channon KM
Circulation; 2003 Jan; 107(1):120-6. PubMed ID: 12515753
[TBL] [Abstract][Full Text] [Related]
7. Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator.
Simoncini T; Varone G; Fornari L; Mannella P; Luisi M; Labrie F; Genazzani AR
Endocrinology; 2002 Jun; 143(6):2052-61. PubMed ID: 12021169
[TBL] [Abstract][Full Text] [Related]
8. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha.
Lu Q; Pallas DC; Surks HK; Baur WE; Mendelsohn ME; Karas RH
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17126-31. PubMed ID: 15569929
[TBL] [Abstract][Full Text] [Related]
9. Estrogen modulation of endothelial nitric oxide synthase.
Chambliss KL; Shaul PW
Endocr Rev; 2002 Oct; 23(5):665-86. PubMed ID: 12372846
[TBL] [Abstract][Full Text] [Related]
10. Vascular cell signaling by membrane estrogen receptors.
Hisamoto K; Bender JR
Steroids; 2005; 70(5-7):382-7. PubMed ID: 15862821
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression.
Sumi D; Ignarro LJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14451-6. PubMed ID: 14610283
[TBL] [Abstract][Full Text] [Related]
12. Estrogen actions in the cardiovascular system.
Mendelsohn ME
Climacteric; 2009; 12 Suppl 1():18-21. PubMed ID: 19811235
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.
Simoncini T; Mannella P; Fornari L; Varone G; Caruso A; Genazzani AR
Endocrinology; 2003 Aug; 144(8):3449-55. PubMed ID: 12865324
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of estrogen action in the cardiovascular system.
Mendelsohn ME
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):337-43. PubMed ID: 11162942
[No Abstract] [Full Text] [Related]
15. Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression.
Liang M; Ekblad E; Lydrup ML; Nilsson BO
Cell Tissue Res; 2003 Jul; 313(1):63-70. PubMed ID: 12827494
[TBL] [Abstract][Full Text] [Related]
16. Drug targeting of estrogen receptor signaling in the cardiovascular system: preclinical and clinical studies.
Sanz-González SM; Cano A; Valverde MA; Hermenegildo C; Andrés V
Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):107-22. PubMed ID: 15320794
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 beta-estradiol's effects on vascular biology.
Joswig M; Hach-Wunderle V; Ziegler R; Nawroth PP
Exp Clin Endocrinol Diabetes; 1999; 107(8):477-87. PubMed ID: 10612478
[TBL] [Abstract][Full Text] [Related]
18. Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-beta.
Maggi A; Cignarella A; Brusadelli A; Bolego C; Pinna C; Puglisi L
Circulation; 2003 Jul; 108(2):211-7. PubMed ID: 12821541
[TBL] [Abstract][Full Text] [Related]
19. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications.
Stefano GB; Peter D
Med Sci Monit; 2001; 7(5):1066-74. PubMed ID: 11535959
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells.
Li L; Haynes MP; Bender JR
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4807-12. PubMed ID: 12682286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
